Bio-View Ltd (TLV:BIOV)
21.40
+0.20 (0.94%)
Sep 14, 2025, 10:36 AM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 28.68 million as of September 12, 2025. Its market cap has decreased by -6.75% in one year.
Market Cap
28.68M
Enterprise Value
22.69M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.40
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 28.68M, a decrease of -52.04%. That is a compound annual growth rate of -3.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 28.41M | -20.40% |
Dec 31, 2024 | 35.69M | -21.62% |
Dec 31, 2023 | 45.53M | -10.12% |
Dec 29, 2022 | 50.66M | 13.09% |
Dec 30, 2021 | 44.79M | -20.07% |
Dec 31, 2020 | 56.04M | 29.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 76.30B |
Danel (Adir Yeoshua) | 2.90B |
Kamada | 1.36B |
SofWave Medical | 979.20M |
Bait Bakfar | 979.07M |
BrainsWay | 973.41M |
Novolog (Pharm-Up 1966) | 757.12M |
Ilex Medical | 708.32M |